Paul Foley

2 months ago | lexology.com | Natasha Hood |Sarah Sinclair |Scott Thompson |John Conlan |Stephanie de Groot |Paul Foley | +4 more

At the end of 2024, Transpower, along with Northland’s electricity distribution businesses Northpower and Top Energy, released their Resilience, Reliability and an Energy Bridge – Te Tai Tokerau Northland discussion paper. This paper followed the June 2024 Northland tower collapse which cut electricity to 88,000 people and caused a financial loss of more than $37.5 million.

Oct 25, 2024 | onlinelibrary.wiley.com | Paul Foley |Paul Kalra |John Cleland |Mark C. Petrie

Introduction Iron deficiency is common in patients with heart failure and clinical trials suggest that correction with high-dose intravenous (IV) iron improves symptoms and quality of life and reduces the risk of heart failure hospitalization.1-3 There is a theoretical risk that iron supplements might increase the risk or severity of infection.

Oct 4, 2024 | sociable.co | Paul Foley

In this episode of Brains Byte Back, we explore the future of neurotechnology with a special guest, Israel Gasperin, founder and CEO of Zentrela. Israel's company is leading the charge in using artificial intelligence (AI) to analyze brainwaves, developing groundbreaking tools that measure cognitive impairment in ways traditional drug tests can’t. In 2018, the historic legalization of cannabis in Canada is where Zentrela really took off.

Oct 3, 2024 | sociable.co | Paul Foley

In this episode of Brains Byte Back, we explore the future of neurotechnology with a special guest, Israel Gasperin, founder and CEO of Zentrela. Israel's company is leading the charge in using artificial intelligence (AI) to analyze brainwaves, developing groundbreaking tools that measure cognitive impairment in ways traditional drug tests can’t. In 2018, the historic legalization of cannabis in Canada is where Zentrela really took off.

Oct 2, 2024 | sociable.co | Paul Foley

In this episode of Brains Byte Back, we explore the future of neurotechnology with a special guest, Israel Gasperin, founder and CEO of Zentrela. Israel's company is leading the charge in using artificial intelligence (AI) to analyze brainwaves, developing groundbreaking tools that measure cognitive impairment in ways traditional drug tests can’t. In 2018, the historic legalization of cannabis in Canada is where Zentrela really took off.